Atlas Trials

A Trial of FANG™ Vaccine for Participants With Ovarian Cancer

Clinical trial NCT01309230 · COMPLETED

Trial details

NCT number
NCT01309230
Sponsor
Gradalis, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2011-03-08
Primary completion
2022-02-02
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.